Volume 1 Supplement 1

Safety in Health

Open Access

Insulin Prescription Charts at a University Hospital: High Variability of Design Characteristics

  • Julia Kopanz1Email author,
  • Katharina M Neubauer1,
  • Gerald Sendlhofer2, 3,
  • Barbara Semlitsch1,
  • Andreas Pak4,
  • Thomas R Pieber1 and
  • Johannes Plank5
Safety in Health20151(Suppl 1):A21

DOI: 10.1186/2056-5917-1-S1-A21

Published: 30 October 2015

Background

Diabetes mellitus exists in approximately 10% of hospitalized patients and hyperglycemia arises in 32 to 38% of patients in community hospitals [13]. Hyperglycemia is associated with increased morbidity, mortality and hospital costs, regardless of whether a hospitalized patient has a known history of diabetes or not [1, 4].

Insulin has frequently been reported to be in the list of top 10 high alert medicines worldwide. The subcutaneous insulin prescribing chart provides a common tool for consistent communication, documentation, interpretation and administration of insulin orders. Evidence indicates that outcomes and safety can be compromised when significant variations in patient care exist [5]. Our objective was to evaluate the quality of design characteristics of subcutaneous insulin prescription charts at a University Hospital.

Materials and methods

The University Hospital Graz (Austria) consists of 14 adult inpatient departments with 39 general wards. In the past, subcutaneous insulin prescription charts were mainly developed on an individual base by each ward. We collected the currently used subcutaneous insulin prescription charts from all wards from the 1st of April 2015 to the 1st of June 2015, and analyzed them regarding quality parameters, accordance to international and local standards [6, 7].

Results

20 different charts for in-hospital insulin prescription are currently used at the 39 wards at the University Hospital.

Out of these, 8 are designed for documentation of subcutaneous insulin prescription only and 5 allow combined documentation of insulin and other forms of antihyperglycemic therapy. 3 charts are designed to closely (hourly) monitor various vital parameters and 4 charts document insulin therapy combined with the general inpatient medication charts. Selected quality parameters of insulin prescription charts are presented in table 1.
Table 1

Quality parameters of 20 currently used insulin prescription charts [n (%)]

Marked space provided for:

Yes, n (%)

Patient Identification and Characteristics

patient identification label

10 (50)

 

name

9 (45)

 

declaration of ward

10 (50)

 

no label, no name

2 (10)

 

type of diabetes

1 (5)

 

HbA1cª

7 (35)

 

BMIb or body weight/height

8 (40)

Treatment Issues

Adequate documentation of insulin therapy possible?

9 (45)

 

Ordering of bgc sampling frequency per day possible?

0 (0)

 

Identification of prescribing physician (initials) possible?

2 (10)

 

Identification of insulin administering nurse (initials) possible?

5 (25)

 

Is a bgc target range predefined?

0 (0)

 

Is a hypoglycemic range predefined?

0 (0)

 

Is a hyperglycemic range predefined?

0 (0)

 

Documentation for correctional insulin for hyperglycemia possible?

2 (10)

 

Documentation for hypoglycemic treatment possible?

0 (0)

ª glycated hemoglobin. b body mass index. c blood glucose.

Conclusion

A distinct variability in design characteristics of insulin prescription charts was found at the University Hospital Graz. This heterogeneity increases the already prevalent complexity of insulin therapy and glycemic management in hospitalized patients. Thus, standardization of a subcutaneous insulin prescribing chart across the wards with guidance including support for correction-schedule may impact the quality of patient care and safety.

Acknowledgements

The authors thank all the participating departments for collaboration and acknowledge Lydia Jantscher for questionnaire analysis.

Declarations

Authors’ Affiliations

(1)
Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz
(2)
Department of Quality and Risk Management, University Hospital Graz
(3)
Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz
(4)
Department of Controlling, University Hospital Graz
(5)
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz

References

  1. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al: Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012, 97 (1): 16-38.PubMedView ArticleGoogle Scholar
  2. Rayman G, Service NH: National Diabetes Inpatient Audit 2013. 2014, accessed June-11-2015, [http://www.hscic.gov.uk/catalogue/PUB13662/nati-diab-inp-audi-13-nat-rep.pdf]Google Scholar
  3. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes. J Clin Endocrinol Metab. 2002, 87 (3): 978-982.PubMedView ArticleGoogle Scholar
  4. Schmeltz LR, Ferrise C: Glycemic Management in the Inpatient Setting. Hosp Pract (1995). 2012, 40 (2): 44-55.View ArticleGoogle Scholar
  5. Christofidis MJ, Horswill MS, Hill A, McKimmie BM, Visser T, Watson MO: Task Analysis and Heuristic Analysis of Insulin Charts: Final report prepared for the Australian Commission on Safety and Quality in Health Care: 2 February 2012. accessed June-11-2015] accessed June-11-2015, [http://www.safetyandquality.gov.au/wp-content/uploads/2012/06/56679-Insulin-charts-heuristic-analysis-2-Feb-2011-Final-Report.pdf]
  6. National Diabetes Inpatient Audit. Hospital Characteristics Questionnaire. 2013, accessed June-11-2015, [http://www.hscic.gov.uk/diabetesinpatientaudit]
  7. National Diabetes Inpatient Audit. Bedside Audit Questionnaire. 2013, accessed June-11-2015, [http://www.hscic.gov.uk/diabetesinpatientaudit]

Copyright

© Kopanz et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement